$SLNO
SOLENO THERAPEUTICS INC

2017 Q3 Form 10-Q Financial Statement

#000162828017008596 Filed on August 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2017 Q2 2016 Q4
Revenue $0.00 $1.000K $0.00
YoY Change -100.0% -50.0% -100.0%
Cost Of Revenue $42.00K
YoY Change -17.65%
Gross Profit -$41.00K
YoY Change -16.33%
Gross Profit Margin -4100.0%
Selling, General & Admin $1.685M $2.195M $1.540M
YoY Change 33.73% 38.22% -30.32%
% of Gross Profit
Research & Development $946.0K $773.0K $290.0K
YoY Change 33.62% 17.48% -77.34%
% of Gross Profit
Depreciation & Amortization $460.0K $420.0K $40.00K
YoY Change 1433.33% 950.0% -33.33%
% of Gross Profit
Operating Expenses $2.631M $2.968M $1.830M
YoY Change 33.69% 32.15% -47.56%
Operating Profit -$2.631M -$2.968M
YoY Change 33.69% 29.32%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $139.0K -$88.00K $410.0K
YoY Change -27.23% 22.22% -37.88%
Pretax Income -$2.490M -$3.060M -$1.420M
YoY Change 39.89% 94.9% -50.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.786M -$3.969M -$2.610M
YoY Change 37.67% 12.98% -8.1%
Net Earnings / Revenue -396900.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$391.9K -$417.0K -$818.2K
COMMON SHARES
Basic Shares Outstanding 47.92M shares 47.59M shares 15.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2017 Q2 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.650M $7.550M $2.730M
YoY Change 4.24% 202.0% -50.27%
Cash & Equivalents $5.647M $7.547M $2.726M
Short-Term Investments
Other Short-Term Assets $750.0K $2.610M $290.0K
YoY Change 188.46% 1205.0% 38.1%
Inventory $164.0K $0.00
Prepaid Expenses
Receivables $0.00 $3.000K $3.000K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.390M $10.32M $3.801M
YoY Change -1.8% 174.71% -40.64%
LONG-TERM ASSETS
Property, Plant & Equipment $55.00K $53.00K $42.02K
YoY Change -52.59% -55.08% -50.99%
Goodwill $718.0K
YoY Change -21.68%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $126.0K $126.0K $125.5K
YoY Change 0.0% 65.79% -82.52%
Total Long-Term Assets $19.99M $20.06M $1.764M
YoY Change 1009.43% 1027.77% -1.86%
TOTAL ASSETS
Total Short-Term Assets $6.390M $10.32M $3.801M
Total Long-Term Assets $19.99M $20.06M $1.764M
Total Assets $26.38M $30.38M $5.565M
YoY Change 217.51% 448.89% -32.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $642.0K $1.029M $410.5K
YoY Change -25.52% 7.52% -40.94%
Accrued Expenses $980.0K $880.0K $1.170M
YoY Change 6.52% -6.38% -28.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.731M $2.122M $1.707M
YoY Change -2.59% 11.63% -46.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.132M $1.132M $61.74K
YoY Change 477.55% 466.0% -43.57%
Total Long-Term Liabilities $1.132M $1.132M $61.74K
YoY Change 477.55% 466.0% -43.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.731M $2.122M $1.707M
Total Long-Term Liabilities $1.132M $1.132M $61.74K
Total Liabilities $3.172M $3.693M $2.130M
YoY Change 60.77% 75.77% -57.21%
SHAREHOLDERS EQUITY
Retained Earnings -$109.0M -$105.2M -$98.31M
YoY Change 13.9% 13.15% 13.99%
Common Stock $132.2M $131.9M $101.7M
YoY Change 30.33% 37.98% 13.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.21M $26.69M $3.435M
YoY Change
Total Liabilities & Shareholders Equity $26.38M $30.38M $5.565M
YoY Change 217.51% 448.89% -32.15%

Cashflow Statement

Concept 2017 Q3 2017 Q2 2016 Q4
OPERATING ACTIVITIES
Net Income -$3.786M -$3.969M -$2.610M
YoY Change 37.67% 12.98% -8.1%
Depreciation, Depletion And Amortization $460.0K $420.0K $40.00K
YoY Change 1433.33% 950.0% -33.33%
Cash From Operating Activities -$2.040M -$3.000M -$2.690M
YoY Change -26.88% -25.74% -20.41%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $140.0K $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $140.0K $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0% -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -2.040M -3.000M -2.690M
Cash From Investing Activities 140.0K 0.000 0.000
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -1.900M -3.000M -2.690M
YoY Change -165.29% -24.81% -444.87%
FREE CASH FLOW
Cash From Operating Activities -$2.040M -$3.000M -$2.690M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$2.040M -$3.000M -$2.690M
YoY Change -26.88% -25.37% -23.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
capn Noncash Expense On Shares Issued
NoncashExpenseOnSharesIssued
0 USD
CY2016Q1 capn Additional Operating Lease Office Space
AdditionalOperatingLeaseOfficeSpace
5265 sqft
capn Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-1122000 USD
capn Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
159000 USD
capn Classof Warrant Or Right Liquidated Damages Amount Percentof Volume Weighted Average Price
ClassofWarrantOrRightLiquidatedDamagesAmountPercentofVolumeWeightedAveragePrice
0.01
CY2015Q1 capn Lessee Leasing Arrangements Operating Leases Increasesto Monthly Payments Term
LesseeLeasingArrangementsOperatingLeasesIncreasestoMonthlyPaymentsTerm
P2Y
CY2015Q3 capn Lessee Leasing Arrangements Operating Leases Increasesto Monthly Payments Term
LesseeLeasingArrangementsOperatingLeasesIncreasestoMonthlyPaymentsTerm
P3Y
capn Noncash Expense On Shares Issued
NoncashExpenseOnSharesIssued
602000 USD
capn Noncashor Part Noncash Acquisition Contingent Consideration
NoncashorPartNoncashAcquisitionContingentConsideration
0 USD
capn Noncashor Part Noncash Acquisition Contingent Consideration
NoncashorPartNoncashAcquisitionContingentConsideration
1090000 USD
capn Noncashor Part Noncash Acquisition Valueof Assets Acquired But Not Yet Paid
NoncashorPartNoncashAcquisitionValueofAssetsAcquiredButNotYetPaid
0 USD
capn Noncashor Part Noncash Acquisition Valueof Assets Acquired But Not Yet Paid
NoncashorPartNoncashAcquisitionValueofAssetsAcquiredButNotYetPaid
349000 USD
capn Sharebased Compensation Arrangementby Sharebased Payment Award Plan Amendment Numberof Additional Shares Authorized
SharebasedCompensationArrangementbySharebasedPaymentAwardPlanAmendmentNumberofAdditionalSharesAuthorized
8929188 shares
CY2017Q1 capn Stock Issued During Period Shares Debt Issuances
StockIssuedDuringPeriodSharesDebtIssuances
8333333 shares
CY2017Q2 capn Working Capital
WorkingCapital
6700000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5495000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2502000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2726000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7547000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2993000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4821000 USD
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001484565
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47922838 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
SOLENO THERAPEUTICS INC
dei Trading Symbol
TradingSymbol
CAPN
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
411000 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1029000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3000 USD
CY2016Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1050000 USD
CY2017Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
879000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
101730000 USD
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
131807000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
218000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
354000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
443000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
628000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13971325 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24641957 shares
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
8171 sqft
CY2016Q4 us-gaap Assets
Assets
5565000 USD
CY2017Q2 us-gaap Assets
Assets
30381000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
3801000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
10318000 USD
CY2016Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
790000 USD
CY2017Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
2323000 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1100000 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1100000 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-19000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-5000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-2070000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1428000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-2000 USD
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16786952 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47587647 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16786952 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47587647 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
17000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
48000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2220000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
51000 USD
us-gaap Cost Of Revenue
CostOfRevenue
69000 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
42000 USD
us-gaap Cost Of Revenue
CostOfRevenue
42000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
45000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
570000 USD
CY2016Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.07
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.16
CY2017Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.01
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.03
CY2016Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
1584000 USD
CY2017Q2 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 USD
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2000000 USD
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
56000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1095000 USD
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
32000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
101000 USD
CY2016Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-94000 USD
CY2017Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1423000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3273000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2195000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3214000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
-49000 USD
us-gaap Gross Profit
GrossProfit
-67000 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
-41000 USD
us-gaap Gross Profit
GrossProfit
-38000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2367000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4340000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3239000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-20000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-373000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-193000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
670000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
163000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
64000 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0 USD
CY2017Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
27000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
0 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5486000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.15
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.29
CY2017Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.06
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.14
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1146000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2362000 USD
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-727000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1370000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
78000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
270000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2000 USD
CY2016Q2 us-gaap Interest Income Other
InterestIncomeOther
0 USD
us-gaap Interest Income Other
InterestIncomeOther
0 USD
CY2017Q2 us-gaap Interest Income Other
InterestIncomeOther
3000 USD
us-gaap Interest Income Other
InterestIncomeOther
4000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 USD
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
128000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2017Q2 us-gaap Inventory Net
InventoryNet
164000 USD
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9000 USD
us-gaap Inventory Write Down
InventoryWriteDown
40000 USD
CY2015Q3 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P4Y
CY2016Q4 us-gaap Liabilities
Liabilities
2130000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
3693000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5565000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30381000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1707000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2122000 USD
CY2016Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
246000 USD
CY2017Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
214000 USD
CY2016Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
81000 USD
CY2017Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 USD
CY2016Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
2600000 USD
CY2017Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
7300000 USD
us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
18000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5070000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5070000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3519000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-232000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-20000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-227000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8023000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4947000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5953000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-3513000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6702000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-3966000 USD
CY2016Q2 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
16000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6856000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3210000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4785000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
22000 USD
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
23300 USD
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
325000 USD
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
343000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
126000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
126000 USD
CY2016Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0 USD
CY2017Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
19884000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
62000 USD
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1132000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
113000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-72000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
983000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-29000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-701000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
2246000 USD
us-gaap Operating Expenses
OperatingExpenses
5256000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
3169000 USD
us-gaap Operating Expenses
OperatingExpenses
4747000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2295000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5323000 USD
CY2017Q2 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0 USD
us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
602000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
223000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
247000 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
246000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
70000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
658000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1623000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
974000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1506000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000 USD
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.61
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53060868 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40029547 shares
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98312000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105200000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105167000 USD
CY2017Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.96
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
2000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
4000 USD
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
165000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
360000 USD
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27000 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.81
CY2017Q1 us-gaap Share Price
SharePrice
0.77
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Stock Issued1
StockIssued1
18764000 USD
CY2017Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
18916940 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3435000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
26688000 USD
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15528922 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15162520 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reported amounts of expenses in the financial statements and accompanying notes. Actual results could differ from those</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">estimates. Key estimates included in the financial statements include the valuation of: deferred income tax assets, liability and equity instruments, stock-based compensation, acquired intangibles, contingent earn-out consideration, and allowances for accounts receivable and inventory.</font></div></div>

Files In Submission

Name View Source Status
0001628280-17-008596-index-headers.html Edgar Link pending
0001628280-17-008596-index.html Edgar Link pending
0001628280-17-008596.txt Edgar Link pending
0001628280-17-008596-xbrl.zip Edgar Link pending
capn-20170630.xml Edgar Link completed
capn-20170630.xsd Edgar Link pending
capn-20170630_cal.xml Edgar Link unprocessable
capn-20170630_def.xml Edgar Link unprocessable
capn-20170630_lab.xml Edgar Link unprocessable
capn-20170630_pre.xml Edgar Link unprocessable
ex-31120170630x10q.htm Edgar Link pending
ex-31220170630x10q.htm Edgar Link pending
ex-32120170630x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
slno-20170630x10q.htm Edgar Link pending